Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155262 | SCV000204948 | uncertain significance | not specified | 2014-07-16 | criteria provided, single submitter | clinical testing | The Arg250Trp variant in OTOF has not been previously reported in individuals wi th hearing loss, but was identified in 0.07% (3/4406) of African American chromo somes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/, dbSNP rs373680242). Computational prediction tools and conservation analyses sug gest that the Arg250Trp variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical si gnificance of the Arg250Trp variant is uncertain. |
Gene |
RCV001731485 | SCV001983107 | uncertain significance | not provided | 2021-10-15 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001731485 | SCV003280313 | likely benign | not provided | 2024-06-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003343662 | SCV004052792 | uncertain significance | Inborn genetic diseases | 2023-08-08 | criteria provided, single submitter | clinical testing | The c.748C>T (p.R250W) alteration is located in exon 8 (coding exon 8) of the OTOF gene. This alteration results from a C to T substitution at nucleotide position 748, causing the arginine (R) at amino acid position 250 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |